Mice in a Parkinson’s disease model treated at higher doses with the anti-anxiety medication buspirone had lesser evidence of nerve cell degeneration in the brain and more normalized behaviors than untreated mice, a pair of researchers in Australia reported. “To our knowledge, this is the first study to investigate the ability…
Older age at disease onset among people with Parkinson’s is associated with a more rapid increase in the severity of motor symptoms, as well as a faster decline in health-related quality of life, a new study found. According to investigators, understanding the factors underlying the development of symptoms “is…
Early on in the COVID-19 pandemic, there was a sharp drop in admissions to nursing homes and emergency rooms among adults with Parkinson’s disease and those with dementia, according to a new study from Canada. The study also suggests that virtual visits with doctors have become much more common…
Some people with Parkinson’s disease find that using cannabis products helps to ease certain symptoms, according to results from a survey. The findings notably suggest that cannabis products with high levels of the chemical THC are more likely to induce both positive and negative effects in Parkinson’s patients. “These…
Zhittya Genesis Medicine is hosting a webinar next week to provide information about the recently announced “Compassionate Use Clinical Trial” of the company’s lead therapy for Parkinson’s disease. The webinar is taking place on Tuesday, Feb. 1, at 3 p.m. Pacific time (6 p.m. Eastern). Registration is…
An international team of scientists is calling for more research about how to better care for women with Parkinson’s disease (PD). “Given the millions of women affected worldwide with PD, and the known differences in this disease’s manifestations and effects between genders, remarkably very little has been done to…
The U.S. Food and Drug Administration (FDA) has issued a partial clinical hold in response to an application by Yumanity Therapeutics requesting permission to begin clinical testing in the U.S. of YTX-7739 for Parkinson’s disease. With this decision, the FDA is allowing Yumanity to conduct a planned clinical…
The protein alpha-synuclein, which has a well-established role in the development of Parkinson’s disease, is necessary for the body to mount a normal immune response against infections. “This study provides further evidence that αS [alpha-synuclein], the protein intimately linked with the pathogenesis of PD [Parkinson’s disease], is a critical…
The Michael J. Fox Foundation has awarded $5.2 million to scientists at Arizona State University (ASU) to support three research projects exploring new treatment options for Parkinson’s disease. The projects will be led by Jeffrey Kordower, PhD, founding director of the Banner Neurodegenerative Disease Research Center at ASU.
Adding a plant-derived agent called Withania somnifera, used in traditional Ayurvedic medicine and thought to help with disturbed sleep, to the insomnia medicines given a woman with Parkinson’s disease appears to have eased her insomnia and completely alleviated her restless leg syndrome, researchers in India report. The case report, “…
Get regular updates to your inbox.